Third Avenue Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.97M | Hold |
189,493
| – | – | 1.23% | 30 |
|
|
2025
Q1 | $6.21M | Hold |
189,493
| – | – | 1.24% | 30 |
|
|
2024
Q4 | $6.85M | Hold |
189,493
| – | – | 1.33% | 27 |
|
|
2024
Q3 | $5.91M | Buy |
189,493
+375
| +0.2% | +$11.7K | 0.97% | 38 |
|
|
2024
Q2 | $5.06M | Buy |
189,118
+29,401
| +18% | +$786K | 0.87% | 40 |
|
|
2024
Q1 | $5.45M | Hold |
159,717
| – | – | 0.87% | 41 |
|
|
2023
Q4 | $4.62M | Buy |
159,717
+43,168
| +37% | +$1.25M | 0.76% | 41 |
|
|
2023
Q3 | $3.27M | Buy |
116,549
+49,487
| +74% | +$1.39M | 0.55% | 46 |
|
|
2023
Q2 | $2.02M | Buy |
67,062
+64,602
| +2,626% | +$1.94M | 0.33% | 46 |
|
|
2023
Q1 | $89.1K | Hold |
2,460
| – | – | 0.02% | 54 |
|
|
2022
Q4 | $87.7K | Hold |
2,460
| – | – | 0.02% | 55 |
|
|
2022
Q3 | $84K | Hold |
2,460
| – | – | 0.02% | 53 |
|
|
2022
Q2 | $72K | Buy |
+2,460
| New | +$72K | 0.01% | 56 |
|